The logo of Bayer is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany, Feb 24, 2014.
Operating, or underlying profit before special items grew 2.8% to 9.5 billion euros, while revenues rose 4.5% to reach 39.6 billion, adjusting for price and currency effects. A first federal case got underway this week, also in California, one of seven trials scheduled for this year. At the moment blockbuster drugs, including anticoagulant Xarelto or cancer treatments Stivarga and Xofigo, bring in 6.8 billion euros of revenue a year.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: msianinsight - 🏆 8. / 63 Read more »
Source: malaymail - 🏆 1. / 86 Read more »